Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Functional proteomics outlines the complexity of breast cancer molecular subtypes.

Gámez-Pozo A, Trilla-Fuertes L, Berges-Soria J, Selevsek N, López-Vacas R, Díaz-Almirón M, Nanni P, Arevalillo JM, Navarro H, Grossmann J, Gayá Moreno F, Gómez Rioja R, Prado-Vázquez G, Zapater-Moros A, Main P, Feliú J, Martínez Del Prado P, Zamora P, Ciruelos E, Espinosa E, Fresno Vara JÁ.

Sci Rep. 2017 Aug 30;7(1):10100. doi: 10.1038/s41598-017-10493-w.

2.

Are Mast Cells MASTers in Cancer?

Varricchi G, Galdiero MR, Loffredo S, Marone G, Iannone R, Marone G, Granata F.

Front Immunol. 2017 Apr 12;8:424. doi: 10.3389/fimmu.2017.00424. eCollection 2017. Review.

3.

The relationship between breast cancer molecular subtypes and mast cell populations in tumor microenvironment.

Glajcar A, Szpor J, Pacek A, Tyrak KE, Chan F, Streb J, Hodorowicz-Zaniewska D, Okoń K.

Virchows Arch. 2017 May;470(5):505-515. doi: 10.1007/s00428-017-2103-5. Epub 2017 Mar 18.

4.

Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation.

Szalayova G, Ogrodnik A, Spencer B, Wade J, Bunn J, Ambaye A, James T, Rincon M.

Breast Cancer Res Treat. 2016 Jun;157(3):461-74. doi: 10.1007/s10549-016-3839-3. Epub 2016 Jun 1.

5.

Tumor-Associated Mast Cells in Thyroid Cancer.

Visciano C, Prevete N, Liotti F, Marone G.

Int J Endocrinol. 2015;2015:705169. doi: 10.1155/2015/705169. Epub 2015 Aug 26. Review.

6.

Targeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategy.

Ammendola M, Leporini C, Marech I, Gadaleta CD, Scognamillo G, Sacco R, Sammarco G, De Sarro G, Russo E, Ranieri G.

Biomed Res Int. 2014;2014:154702. doi: 10.1155/2014/154702. Epub 2014 Sep 11. Review.

7.

The Role of Mast Cells in Molding the Tumor Microenvironment.

Rigoni A, Colombo MP, Pucillo C.

Cancer Microenviron. 2015 Dec;8(3):167-76. doi: 10.1007/s12307-014-0152-8. Epub 2014 Sep 7.

8.

Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor.

Zaiss DM, van Loosdregt J, Gorlani A, Bekker CP, Gröne A, Sibilia M, van Bergen en Henegouwen PM, Roovers RC, Coffer PJ, Sijts AJ.

Immunity. 2013 Feb 21;38(2):275-84. doi: 10.1016/j.immuni.2012.09.023. Epub 2013 Jan 17.

9.

Genetically determined inflammatory-response related cytokine and chemokine transcript profiles between mammary carcinoma resistant and susceptible rat strains.

Devapatla B, Sanders J, Samuelson DJ.

Cytokine. 2012 Aug;59(2):223-7. doi: 10.1016/j.cyto.2012.04.037. Epub 2012 May 18.

10.

Contribution of Fibroblast and Mast Cell (Afferent) and Tumor (Efferent) IL-6 Effects within the Tumor Microenvironment.

Hugo HJ, Lebret S, Tomaskovic-Crook E, Ahmed N, Blick T, Newgreen DF, Thompson EW, Ackland ML.

Cancer Microenviron. 2012 Apr;5(1):83-93. doi: 10.1007/s12307-012-0098-7. Epub 2012 Feb 8.

11.

Mast cell accumulation in glioblastoma with a potential role for stem cell factor and chemokine CXCL12.

Põlajeva J, Sjösten AM, Lager N, Kastemar M, Waern I, Alafuzoff I, Smits A, Westermark B, Pejler G, Uhrbom L, Tchougounova E.

PLoS One. 2011;6(9):e25222. doi: 10.1371/journal.pone.0025222. Epub 2011 Sep 19.

12.

Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma.

Bograd AJ, Suzuki K, Vertes E, Colovos C, Morales EA, Sadelain M, Adusumilli PS.

Cancer Immunol Immunother. 2011 Nov;60(11):1509-27. doi: 10.1007/s00262-011-1103-6. Epub 2011 Sep 13. Review.

13.

Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression.

Strouch MJ, Cheon EC, Salabat MR, Krantz SB, Gounaris E, Melstrom LG, Dangi-Garimella S, Wang E, Munshi HG, Khazaie K, Bentrem DJ.

Clin Cancer Res. 2010 Apr 15;16(8):2257-65. doi: 10.1158/1078-0432.CCR-09-1230. Epub 2010 Apr 6.

14.

Identification of novel kinase targets for the treatment of estrogen receptor-negative breast cancer.

Speers C, Tsimelzon A, Sexton K, Herrick AM, Gutierrez C, Culhane A, Quackenbush J, Hilsenbeck S, Chang J, Brown P.

Clin Cancer Res. 2009 Oct 15;15(20):6327-40. doi: 10.1158/1078-0432.CCR-09-1107. Epub 2009 Oct 6.

15.

T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis.

Gounaris E, Blatner NR, Dennis K, Magnusson F, Gurish MF, Strom TB, Beckhove P, Gounari F, Khazaie K.

Cancer Res. 2009 Jul 1;69(13):5490-7. doi: 10.1158/0008-5472.CAN-09-0304.

16.

Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation.

Maltby S, Khazaie K, McNagny KM.

Biochim Biophys Acta. 2009 Aug;1796(1):19-26. doi: 10.1016/j.bbcan.2009.02.001. Epub 2009 Feb 21. Review.

17.

Mast cells as regulators of adaptive immunity to tumours.

Wasiuk A, de Vries VC, Hartmann K, Roers A, Noelle RJ.

Clin Exp Immunol. 2009 Feb;155(2):140-6. doi: 10.1111/j.1365-2249.2008.03840.x. Epub 2008 Dec 5. Review.

Supplemental Content

Support Center